BACE1-/-mice exhibit endophenotypes typically seen in schizophrenia [101, 102], leading researchers to test whether partial BACE1 inhibition decreases Aβ load while limiting unwanted side effects. The gene discussed is BACE1; the disease is schizophrenia.